Urinary free cortisol is not a biochemical marker of hypertension

被引:12
作者
Krall, Paola
Carvajal, Cristian
Ortiz, Eugenia
Munoz, Carlos
Garrido, Lose Luis
Mosso, Lorena
Fardella, Carlos
机构
[1] Univ Austral Chile, Fac Ciencias, Escuela Grad, Valdivia, Chile
[2] Pontificia Univ Catolica Chile, Fac Med, Dept Endocrinol, Lab Endocrinol & Biol Mol, Santiago, Chile
关键词
essential hypertension; cortisol; renin; aldosterone; glucocorticoid receptor; glucocorticoid resistance;
D O I
10.1016/j.amjhyper.2006.09.017
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Increasing evidence suggests that glucocorticoids might play a role in blood pressure (BP) control. These reports show that cortisol (F) can increase the BP acting on the mineralocorticoid receptor in kidney, brain, heart, and blood vessel. The aim of this study was to evaluate the effects of F in the renal salt and water reabsorption in essential hypertensive patients (EH). Methods: We studied 364 EH and 102 normotensive (NT) subjects. We obtained 24-h urine to measure urinary free cortisol (UFF) and creatinine (Cr). The upper limit of the UFF/Cr ratio was calculated from NT subjects. Patients with a high UFF/Cr ratio underwent dexamethasone suppression test (DST). Blood samples were used to determine plasma renin activity (PRA), aldosterone (SA), F, cortisone (E), urinary Na/K ratios, adrenocorticotrophic hormone levels, and also to purify lymphocytes for binding assays and genetic analysis. Results: In EH subjects the UFF/Cr and F/E ratios were higher than in normotensives (48.3 mu g/g [33.6 to 57.5 mu g/g] v 32.6 mu g/g [5.6 to 34.6 mu g/g], P<.001 and 3.9 mu g/g [3.3 to 4.8 mu g/g] v 3.0 mu g/g [2.4 to 3.6 mu g/g], respectively), whereas the SA and PRA levels were similar. The upper limit value for UFF/Cr was set at 51.6 mu g/g. The EH patients with high UFF/Cr (123/364, 34%) had lower PRA (1.5 ng/mL/h [0.9 to 2.5 ng/mL/h] v 2.0 ng/mL/h [1.1 to 3.0 ng/mL/h], P=.012, SA levels (7.1 ng/dL [4.1 to 10.5 ng/dL] v 7.9 ng/dL [5.2 to 11.0 ng/dL], P=.045) and Na/K ratios (3.6 [2.8 to 5.8] v 4.0 [3.1 to 6.6], P <=.05) than those with normal UFF/Cr ratios. We found a slight negative relationship between UFF/Cr and PRA (r = -0.117, P=.031), SA (r = -0.096, P=.058) and Na/K ratios (r = 0.176, P =.059). We did not find significant differences in serum F/E ratios between EH patients with high or normal UFF/Cr (3.9 [3.3 to 5.1] v 3.8 [3.2 to 4.7], P = not significant [NS]) or a correlation between F/E ratio and UFF excretion (r = 0.032, P = NS). We did not find any association between UFF/Cr with systolic BP (P=.349) or diastolic BP (P=.895). Forty EH with the highest UFF/Cr values underwent the DST, which resulted in suppressed serum F in all of them. Binding assays in 4 of 13 EH with the highest UFF/Cr ratio showed a low affinity to dexamethasone (K-d 13.7 to 33.0 nmol/L). The polymerase chain reaction (PCR) amplification of the GR gene (ligand-binding domain exons) did not show mutations or gross alterations. Conclusions: We found an EH subpopulation with abnormally high values of UFF but evidence of only a minor mineralocorticoid action, which was not directly related to the BP elevation, suggesting that another alternative mechanism could be triggering the F-induced hypertension. The origin of hypercortisoluria was not elucidated; however, a subtle glucocorticoid resistance was found in some cases.
引用
收藏
页码:459 / 465
页数:7
相关论文
共 30 条
[1]   CA-repeat polymorphism in intron 1 of HSD11B2 - Effects on gene expression and salt sensitivity [J].
Agarwal, AK ;
Giacchetti, G ;
Lavery, G ;
Nikkila, H ;
Palermo, M ;
Ricketts, M ;
McTernan, C ;
Bianchi, G ;
Manunta, P ;
Strazzullo, P ;
Mantero, F ;
White, PC ;
Stewart, PM .
HYPERTENSION, 2000, 36 (02) :187-194
[2]   CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR [J].
ARRIZA, JL ;
WEINBERGER, C ;
CERELLI, G ;
GLASER, TM ;
HANDELIN, BL ;
HOUSMAN, DE ;
EVANS, RM .
SCIENCE, 1987, 237 (4812) :268-275
[3]   THE NEURONAL MINERALOCORTICOID RECEPTOR AS A MEDIATOR OF GLUCOCORTICOID RESPONSE [J].
ARRIZA, JL ;
SIMERLY, RB ;
SWANSON, LW ;
EVANS, RM .
NEURON, 1988, 1 (09) :887-900
[4]   Variations of the human glucocorticoid receptor gene (NR3C1): Pathological and in vitro mutations.and polymorphisms [J].
Bray, PJ ;
Cotton, RGH .
HUMAN MUTATION, 2003, 21 (06) :557-568
[5]   Biochemical and genetic characterization of 11β- hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives [J].
Carvajal, CA ;
Romero, DG ;
Mosso, LM ;
González, AA ;
Campino, C ;
Montero, J ;
Fardella, CE .
JOURNAL OF HYPERTENSION, 2005, 23 (01) :71-77
[6]   Two homozygous mutations in the 11β-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess [J].
Carvajal, CA ;
Gonzalez, AA ;
Romero, DG ;
González, A ;
Mosso, LM ;
Lagos, ET ;
Hevia, MD ;
Rosati, MP ;
Perez-Acle, TO ;
Gomez-Sanchez, CE ;
Montero, JA ;
Fardella, CE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) :2501-2507
[7]   SYNDROMES OF GLUCOCORTICOID RESISTANCE [J].
CHROUSOS, GP ;
DETERAWADLEIGH, SD ;
KARL, M .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (11) :1113-1124
[8]  
Fardella Carlos E, 2002, Clin Lab, V48, P181
[9]   The role of the 11β-hydroxysteroid dehydrogenase type 2 in human hypertension [J].
Ferrari, P ;
Lovati, E ;
Frey, FJ .
JOURNAL OF HYPERTENSION, 2000, 18 (03) :241-248
[10]   RALES, EPHESUS and redox [J].
Funder, JW .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 93 (2-5) :121-125